Autoimmune Disease Diagnosis Market PDF, Size, Share, Trends, Industry Scope 202

1. Global Autoimmune Disease Diagnosis Market Research and Forecast Report 2021- 2026 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Autoimmune Disease DiagnosisMarket Research Report: According to the latest report by IMARC Group, titled "Autoimmune Disease Diagnosis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026," the global autoimmune disease diagnosis market reached a strong growth in 2020. An autoimmune disease refers to a medical condition that results from an abnormal immune response to a normally functioning body part. The immune system is unable to distinguish between healthy tissues and potentially harmful antigens in this condition. As a result, it releases proteins called autoantibodies to attack the healthy cells that destroy the functioning cells, tissues, and organs of the body. At present, more than 80 types of autoimmune disorders have been identified by scientists that include type I diabetes, psoriasis, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. The diagnosis of these diseases requires a combination of physical examination, antinuclear antibody test (ANA), C-reactive protein (CRP), tissue biopsy and X-rays in order to determine the nature and severity of the condition. Request Free Sample Report: https://www.imarcgroup.com/autoimmune-disease-diagnosis- market/requestsample

4. Report Description and Highlights Report Description Global Autoimmune Disease Diagnosis Market Trends : The global market is primarily driven by the growing prevalence of numerous autoimmune disorders, along with the increasing demand for precise and efficient diagnostic solutions. This has led to the adoption of advanced technologies to conduct multiple tests simultaneously with faster and accurate results. These technologies are also focused on providing an improved diagnosis with higher sensitivity, which is providing an impetus to the market growth. In addition to this, there has been a rising preference for laboratory automation. This, along with the increasing healthcare expenditure, is acting as a major growth-inducing factor. Moreover, numerous government and non-government organizations (NGOs) are undertaking initiatives to spread awareness regarding the diagnosis and treatment of autoimmune disorders. Several research and diagnostics institutes are also investing in programs that aim to develop improved diagnostic methods and novel therapeutic solutions for these medical disorders, which, in turn, is expected to create a positive outlook for the market. Looking forward, the market value is projected to reach a strong growth during the forecast period (2021-2026).

5. Report Description and Highlights Report Description Market Summary: Breakup by Product Type: •Consumables and Assay Kits •Instruments Breakup by Disease Type: •Systemic Autoimmune Disease • Rheumatoid Arthritis • Psoriasis • Systemic Lupus Erythematosus (SLE) • Multiple Sclerosis • Others •Localized Autoimmune Disease • Inflammatory Bowel Disease • Type 1 Diabetes • Thyroid • Others

6. Report Description Report Description and Highlights Breakup by Test Type: •Routine Laboratory Tests •Inflammatory Markers •Autoantibodies and Immunologic Tests •Others Breakup by End-User: •Clinical Laboratories •Hospitals •Others Breakup by Region: •North America • United States • Canada •Asia Pacific • China • Japan • India • South Korea

7. Report Description Report Description and Highlights • • • Australia Indonesia Others •Europe • • • • • • • Germany France United Kingdom Italy Spain Russia Others •Latin America • • • • • • • Brazil Mexico Argentina Columbia Chile Peru Others

8. Report Description Report Description and Highlights •Middle East and Africa Turkey •Saudi Arabia •Iran •United Arab Emirates •Others Note: We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report. Competitive Landscape with Key Players: • Abbott Laboratories • Aesku.Diagnostics GmbH & Co. KG • Beckman Coulter Inc. (Danaher Corporation) • bioMérieux SA (Institut Mérieux) • Bio-Rad Laboratories Inc. • Euroimmun AG (PerkinElmer Inc.) • Hemagen Diagnostics Inc. • Inova Diagnostics Inc. (Werfen Group S.A.) • Myriad Genetics Inc. • Quest Diagnostics Incorporated

9. Report Description Report Description and Highlights • • • • Siemens Healthineers AG (Siemens AG) SQI Diagnostics Thermo Fisher Scientific Inc. Trinity Biotech View Full Report with TOC & List of Figure: https://www.imarcgroup.com/autoimmune-disease- diagnosis-market

10. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

11. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

12. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

13. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com